TotalMarketCap

Boundless Bio

BOLDNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$55.789 M

$2.41 +0.42%

Close of 6 Nov 2026

As of 6 Nov 2026, Boundless Bio (BOLD) has a market capitalization of $55.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$58.2M

Loss-making

Shares outstanding

22,747,985

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #325CleneCLNN$56.2M
  2. #326Xilio TherapeuticsXLO$55.9M
  3. #327Boundless BioBOLD$55.8M
  4. #328RafaelRFL$55.3M
  5. #329Corbus PharmaceuticalsCRBP$54.8M

What if Boundless Bio were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,219,791

Per share 506,138× higher

Bitcoin $1.53T

$66,000.79

Per share 27,386× higher

Apple $5.02T

$216,674.45

Per share 89,906× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Boundless Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.